Omnicell to Release Fourth Quarter 2012 Earnings Results on January 31
Published: Jan 24, 2013
MOUNTAIN VIEW, Calif., Jan. 24, 2013 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities,will hold a conference call Thursday, January 31, to discuss the Company's Fourth Quarter 2012 financial results.
Omnicell Fourth Quarter 2012 earnings conference call and webcast
January 31, 2013, 1:15 p.m. PT
Randall Lipps, chairman, president and chief executive officer
Rob Seim, chief financial officer
The conference call can be monitored by dialing 1-800-696-5518 within the U.S. or 1-706-758-4883 for all other locations. The Conference ID # is 91533597.
The webcast can be accessed at: http://ir.omnicell.com/events.cfm.
Link to the Omnicell website 15 minutes prior to the call to download necessary audio software.
Available starting at 3:30 p.m. PT on January 31, 2013 through 8:59 p.m. PT on February 8, 2013. Dial 1-855-859-2056 within the U.S. and 1-404-537-3406 for all other locations, Conference ID # 91533597.
Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automation and business information solutions enabling hospitals and other healthcare organizations to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a customer's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.
Since 1992, more than 2,600 hospital customers worldwide have utilized Omnicell's medication automation, supply chain, and analytics solutions to enable them to increase patient safety, improve efficiency and address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.
MTS Medication Technologies, a wholly-owned Omnicell subsidiary, is a leader in medication adherence packaging systems designed to improve medication dispensing and administration. MTS enables approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards while optimizing productivity and controlling costs. The MTS product line includes more than 20 packaging machines and 50 types of consumable products.
SOURCE Omnicell, Inc.